ArticleCancers2020

Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma.

Kelly Regan-Fendt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.